In addition, clinical studies have reported that the ANGPTL2 level is a risk factor for lower extremity artery disease and lower extremity amputation in a large cohort of T2DM patients [15, 16], while peripheral arterial diseases and amputation were the ultimate consequences of DFUs. This evidence concerns the gene ANGPTL2 and peripheral arterial disease.